11 Best Medical Device Stocks to Buy Now
On April 16, CNBC reported that Trump's tariffs are building a divide in the medical community.
Abbott Laboratories (ABT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Diamond Hill Capital Ric Dillon | 6,073,765 | $805,684,927 | -8% | 3.69% |
| 2. | Leucadia National Ian Cumming And Joseph Steinberg | 243,548 | $32,306,642 | +23% | 0.29% |
| 3. | Lee Munder Capital Group Lee Munder | 148,737 | $19,729,963 | -8% | 1.31% |
| 4. | Impax Asset Management Ian Simm | 147,623 | $19,582,191 | -64% | 0.12% |
| 5. | Bailard Inc Thomas Bailard | 88,074 | $11,683,061 | +16% | 0.3% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $122.50 | 2,040 | 7,296 | 2021-02-23 | Filing | ||
| $73.40 | 2,000 | Officer | 52,562 | 2019-04-22 | Filing | |
| $72.32 | 100 | Director | 6,400 | 2019-01-31 | Filing | |
| $72.31 | 100 | Director | 6,300 | 2019-01-31 | Filing | |
| $72.33 | 1,800 | Director | 6,200 | 2019-01-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $129.66 | 2,600 | 34,058 | 2025-04-30 | Filing | ||
| $136.65 | 200 | 71,928 | 2025-03-07 | Filing | ||
| $133.82 | 91,167 | 71,928 | 2025-03-06 | Filing | ||
| $138.17 | 949 | 74,381 | 2025-03-03 | Filing | ||
| $138.17 | 562 | 31,970 | 2025-03-03 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 136,977,160 | $18,170,020,263 | 0.38% | |
| 2. | 14,451,305 | $1,916,965,608 | 0.64% | |
| 3. | 13,388,375 | $1,775,968,024 | 0.35% | |
| 4. | 6,951,496 | $922,115,944 | 3.99% | |
| 5. | 5,728,444 | $759,878,097 | 2.77% |
News See All
Abbott Laboratories (ABT) Continued Sixth Straight Quarter of Double-Digit Gains
Mairs & Power, an investment advisor, released the “Mairs & Power Balanced Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Jim Cramer Talked About These 7 Stocks Recently
On Monday, Jim Cramer, host of Mad Money, shared valuable insights from his years of experience as an investor. He stressed the importance of saving consistently, regardless of any excuses.
How Did Jim Cramer’s 12 Bold Predictions Play Out?
During the most recent episode of Mad Money, Jim Cramer revisited the recent turbulence in artificial intelligence stocks, three months after the emergence of DeepSeek, a Chinese AI firm that initially...
15 Best Stocks to Buy During Recession
As per BlackRock, 2025 started with a bumpy ride for the US stocks. That being said, the asset manager believes that the sentiment has been a critical driver, but fundamentals seem to be healthy.
Jim Cramer Defended American Superiority and Discussed These 13 Stocks
In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer highlighted the often-overlooked role of currency fluctuations and explained why a weaker U.S.
Abbott Laboratories (NYSE:ABT) Q1 2025 Earnings Call Transcript
Operator: Good morning, and thank you for standing by. Welcome to Abbott Laboratories' First Quarter 2025 Earnings Conference Call.
10 Innovative Healthcare Stocks to Watch in 2025
In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S. healthcare spending increased 7.5% from 2022 to $4.9 trillion in 2023.
10 Best Dividend Monarchs to Invest in Now
Dividend-focused investors are generally well-acquainted with terms like Dividend Aristocrats and Dividend Kings, but many may not be aware of a lesser-known group called Dividend Monarchs.
Jim Cramer’s Game Plan: 15 Stocks to Watch
He noted the chaotic nature of the current environment and remarked that "this tape has it all," and emphasized how unpredictable developments from the White House have added to the turbulence.
Billionaire Hedge Funds
